Key result
L-carnitine treatment in 9 patients with chronic congestive heart failure resulted in 55% moving to a lower NYHA class and 66% showing overall condition improvement.
Why the study?
Does l-carnitine improve clinical symptoms and exercise tolerance in patients with chronic congestive heart failure and ischemic heart disease?
Population
Cardiomyopathic BIO 14.6 hamsters and patients with chronic congestive heart failure and ischemic heart…
Comparison
L-carnitine. vs FI hamsters and patients without heart failure…
Design
Other
Follow-up
12 weeks (for angina patients)
Authors
Loading...
May warrant caution against routine use in heart failure; leaves open efficacy pending randomized trials.
Does l-carnitine improve clinical symptoms and exercise tolerance in patients with chronic congestive heart failure and ischemic heart disease?
L-carnitine supplementation may improve clinical symptoms and exercise tolerance in patients with heart failure and ischemic heart disease by restoring myocardial fatty acid oxidation.
Kobayashi et al. (1992) studied Chronic congestive heart failure and ischemic heart disease (n=9). L-carnitine was evaluated on Movement to a lower NYHA class. L-carnitine treatment in 9 patients with chronic congestive heart failure resulted in 55% moving to a lower NYHA class and 66% showing overall condition improvement.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: